Meta Pixel
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.


Access Curated Private Market Opportunities

Award-winning Platform Empowering Innovation, Capital and Ambition, Globally

  • 1,582+

    Investors & Deal Makers

  • 10

    Unicorns

  • 14

    Year track record

Homepage

POWERED BY CapitalHQTM

Utilise our cutting-edge AI-powered platform to access curated Private Opportunities. Discover Startups, Scaleups, Fund Managers, Private Equity, Property, Small Cap Listed and Secondary Market Opportunities

Join an exclusive ecosystem of High-Net-Worth, Professional, Institutional, VC and Family Office Investors. Receive personalised deal flow, streamlined information access and access to investment insights from leading global Fund Managers and Investors

QBiotics Group

Pharmaceuticals

Biosignals Diagnostics

Healthtech

SurgiBox Inc.

Medical Devices

Access Exclusive Private Opportunities

Get access to curated growth companies, property opportunities, alternative funds, investment insights and exclusive investor networking events

  • Free Account Set up
  • No transaction fees
  • Direct Access to CEOs and Managers
  • Curated Global Deal Flow

QBiotics Group

Pharmaceuticals

Biosignals Diagnostics

Healthtech

SurgiBox Inc.

Medical Devices

A Personalised Pipeline of Opportunities

Let our AI/ML provide you with personalised, exclusive and consistent deal flow

QBiotics Group

Pharmaceuticals

Biosignals Diagnostics

Healthtech

SurgiBox Inc.

Medical Devices

BetterX

  • Overview
  • Market Opportunity
  • Competitive Advantage
  • Highlights and Milestones
  • Investment Offering

Streamlined Investor Experience

Access the information you want and need, in a structured, clear format.

Trusted by hundreds of companies worldwide

Our international clientele includes leading emerging growth companies, funds, governments, universities, incubators, accelerators and advisory firms.

Premier Investor Events and Conferences

See exclusive pitches, product demos, and talk with founders
In person or online

Venture & Capital – Investment Conference – SYDNEY 2025

29-30 Jul 2025
Learn More

Venture & Capital 2025 – Investment Conference – Singapore

27 Aug 2025
Learn More

News and announcements

Our Clients’ Major Breakthrough and Milestones

Company Updates
Stop Leaving Millions on the Table: The Investor Secret You’re Missing!

In an Australian business landscape increasingly defined by volatility and intense competition for capital, the art of robust stakeholder relations has evolved beyond a mere governance checkbox. For founders, boards, and executive teams, the ability to genuinely inform and engage investors isn’t just about meeting disclosure requirements; it’s a strategic imperative that directly impacts capital […]

Capital Insights
Wholesale Investor and CapitalHQ Sign Exclusive Master Licence with inQ Innovation Global to Provide Access to India’s High-Growth Startup Market

Wholesale Investor and inQ Innovation have forged a strategic partnership, granting global investors direct access to India’s rapidly expanding innovation ecosystem. This exclusive three-year agreement leverages CapitalHQ’s technology to streamline fundraising for Indian startups and expand deal flow for WI’s 45,000-strong investor network, aligning with India’s 2030 Vision for economic growth and innovation.

Capital Insights
EBR Systems: Aussie Medtech Ready to Disrupt $3.6B Heart Failure Market with Leadless Pacemaker

Andrew Shute, Senior Vice President of Business Development at EBR Systems, is confident that his Australian medical device company is poised to make a significant impact on the global cardiac rhythm management market. The focus? A novel leadless pacemaker designed to revolutionise treatment for heart failure patients. After years of development and rigorous clinical trials, […]

See more exiting opportunities on CapitalHQ

Join over 45,000+ sophisticated investors

Join Now